3 Matching Annotations
  1. Oct 2026
    1. 50.198 (3.0)9.2DS 4.6heterozygous pathogenic: c.1029C>G; p.Y343*Normal examinationHS 6.1heterozygous PD: c.235G>A; p.A79TCarrierheterozygous PD: c.296C>T; p.T99I

      Case#:Patient Sample unique ID 5, Infant screened positive at birth (specimens with activity ≤15% of the DMA for enzyme activity and a CLIR screening algorithm result of indeterminate or MPS I)

      DiseaseAssertion:Carrier

      FamilyInfo:None

      CasePresentingHPOs:None

      CaseHPOFreeText:None

      CaseNotHPOs:None

      CaseNotHPOFreeText: Normal examination at follow up after screening positive at birth (specimens with activity ≤15% of the DMA for enzyme activity and a CLIR screening algorithm result of indeterminate or MPS I)

      CaseEnzymeAssay: IDUA activity 0.198 (9.2) umol/L/h (%DMA) during new born screening through dried blood spot (plasma) and 9.2 pmol/punch/h Confirmatory IDUA enzyme measured at follow-up appointment

      CaseUrineGAGs: DS 4.6 g/mol creatinine and HS 6.1 g/mol creatinine (Normal)

      CaseERT:No

      CaseBMT:No

      Variant1:heterozygous pathogenic: c.1029C>G; p.Y343* (Normal examination)

      Variant1ClinVarID: 560781

      Variant1CAID: CA352049896

      Variant2: heterozygous PD: c.235G>A; p.A79T (Carrier)

      Variant2ClinVarID:41682

      Variant2CAID:CA000358

      AdditionalVariants:heterozygous PD: c.296C>T; p.T99I (ClinVarID:53610, CAID:CA326991)

      ParentalGenotype:N/A

      PreviouslyPublished:N/A

    2. 40.280 (4.2)2DS 5.7heterozygous VUS: c.1582C>G; p.P528ANormal examinationHS 3.6heterozygous likely benign: c.240C>Ghomozygous PD: c.235G>A; p.A79Thomozygous PD: c.296C>T; p.T99I

      Case#:Patient Sample unique ID 4, Infant screened positive at birth (specimens with activity ≤15% of the DMA for enzyme activity and a CLIR screening algorithm result of indeterminate or MPS I)

      DiseaseAssertion:None at follow up after screening positive at birth

      FamilyInfo:None

      CasePresentingHPOs:None

      CaseHPOFreeText: None

      CaseNotHPOs:None

      CaseNotHPOFreeText: Normal examination at follow up after screening positive at birth (specimens with activity ≤15% of the DMA for enzyme activity and a CLIR screening algorithm result of indeterminate or MPS I)

      CaseEnzymeAssay: IDUA activity 0.280 (4.2) umol/L/h (%DMA) through dried blood spot during newborn screening and 2 pmol/punch/h Confirmatory IDUA enzyme measured at follow-up appointment

      CaseUrineGAGs: DS 5.7 g/mol creatinine and HS 3.6 g/mol creatinine (Normal)

      CaseERT:No

      CaseBMT:No

      Variant1:heterozygous VUS: c.1582C>G; p.P528A

      Variant1ClinVarID:2880182

      Variant1CAID:CA398172227

      Variant2: heterozygous likely benign: c.240C>G

      Variant2ClinVarID: 4549

      Variant2CAID: CA253209

      AdditionalVariants:homozygous PD: c.235G>A; p.A79T (ClinVarID:41682, CA000358) and homozygous PD: c.296C>T; p.T99I (ClinVarID:53610, CA326991)

      ParentalGenotype:N/A

      PreviouslyPublished:N/A

  2. Aug 2023